During systemic thrombolysis for STEMI, which procedure should be avoided if possible due to bleeding risk?

Prepare for the Emergency Nursing Orientation 3.0 Cardiovascular Emergencies Test. Use interactive flashcards and detailed explanations with multiple choice questions. Enhance your understanding of cardiovascular emergencies and succeed on your exam!

Multiple Choice

During systemic thrombolysis for STEMI, which procedure should be avoided if possible due to bleeding risk?

During systemic thrombolysis for STEMI, bleeding risk is globally elevated because the medication dissolves clots throughout the body, impairing hemostasis. Any procedure that punctures skin or penetrates vessels—such as inserting arterial or central venous lines—creates a bleeding site that can be difficult to control and may lead to serious hemorrhage, hematoma, or even intracranial bleeding. Because of this, unnecessary invasive lines should be avoided or postponed during thrombolysis to minimize bleeding complications. Noninvasive tests like echocardiography (especially transthoracic) have minimal bleeding risk, inhaled therapies such as nebulized bronchodilators do not significantly affect systemic coagulation, and physical therapy itself does not pose the same bleeding threat as vascular access. The key concept is prioritizing procedures to limit bleeding while thrombolysis is active, making invasive line placement the procedure to avoid if possible.

During systemic thrombolysis for STEMI, bleeding risk is globally elevated because the medication dissolves clots throughout the body, impairing hemostasis. Any procedure that punctures skin or penetrates vessels—such as inserting arterial or central venous lines—creates a bleeding site that can be difficult to control and may lead to serious hemorrhage, hematoma, or even intracranial bleeding. Because of this, unnecessary invasive lines should be avoided or postponed during thrombolysis to minimize bleeding complications.

Noninvasive tests like echocardiography (especially transthoracic) have minimal bleeding risk, inhaled therapies such as nebulized bronchodilators do not significantly affect systemic coagulation, and physical therapy itself does not pose the same bleeding threat as vascular access. The key concept is prioritizing procedures to limit bleeding while thrombolysis is active, making invasive line placement the procedure to avoid if possible.

More practice questions